United States-Abraham Accords Cooperation and Security Act of 2025

HR 1794 establishes an "Abraham Accords Office" within the Food and Drug Administration (FDA) to foster regulatory cooperation with countries that signed the Abraham Accords (e.g., UAE, Bahrain). The office, to be created within two years, will provide technical assistance to help these countries align their medical product regulations with FDA standards and facilitate information sharing about U.S. regulatory pathways. It requires the FDA to report to Congress after three years on the office’s progress, including metrics on how many entities it assisted and recommendations for improving collaboration. The bill does not alter existing security protocols and explicitly states it cannot override national security directives.